Omnicell OMCL is advancing toward the industry-defined vision of Autonomous Pharmacy by leveraging automation and advanced services across its cloud-based platform. The strength of the company’s ...

Omnicell expects expansion as customers increase the use of its dispensing systems in more areas within their hospitals and ambulatory care settings. The Central Pharmacy and IV Compounding market ...

Omnicell OMCL is advancing toward the industry-defined vision of Autonomous Pharmacy by leveraging automation and advanced services across its cloud-based platform. The strength of the company’s ...

The market expects Omnicell (OMCL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

Although this is true for many people with iron deficiency, it can be much more complicated. When determining which iron therapy—oral or intravenous (IV)—is right for you, it is important to consider ...

The laboratory is leading the charge in developing the next generation of nuclear reactors, known as Gen-IV reactors. These reactors promise to be safer, more efficient and produce less waste than ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the fourth quarter ...

Stage IV cancers have spread (metastasized) beyond the breast and nearby lymph nodes to other parts of the body. When breast cancer spreads, it most commonly goes to the bones, liver, and lungs. It ...